| Concord Biotech Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
543960
ISIN Demat:
INE338H01029
Book Value(₹): 193.06 NSE Symbol:
CONCORDBIO
Div & Yield(%):
0.60
Market Cap(₹ Cr): 13,062.90 P/E(TTM):
54.22
EPS(TTM):
23.03
Face Value(₹): 1.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,055.07 | 1,200.09 | 1,016.94 | 853.17 | 712.93 |
| Other Income | 52.73 | 44.45 | 33.78 | 35.31 | 23.42 |
| Stock Adjustments | 70.61 | 14.79 | 12.08 | 15.63 | 23.98 |
| Total Income | 1,178.41 | 1,259.33 | 1,062.80 | 904.11 | 760.33 |
| EXPENDITURE : | |||||
| Raw Materials | 316.58 | 320.30 | 241.28 | 195.84 | 187.99 |
| Power and Fuel Cost | 116.20 | 112.23 | 104.97 | 97.65 | 71.64 |
| Other Manufacturing Expenses | 30.77 | 26.18 | 28.00 | 24.93 | 17.10 |
| Selling and Administration Expenses | 100.88 | 99.31 | 91.08 | 82.93 | 67.90 |
| Miscellaneous Expenses | 17.28 | 11.09 | 8.46 | 13.20 | 22.66 |
| Employee Benefit Expenses | 170.19 | 138.93 | 123.05 | 110.28 | 95.69 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 426.53 | 551.29 | 465.97 | 379.27 | 297.34 |
| Interest | 0.77 | 1.04 | 3.18 | 5.18 | 6.13 |
| Gross Profit | 425.76 | 550.25 | 462.79 | 374.09 | 291.21 |
| Depreciation | 74.33 | 54.37 | 53.59 | 54.03 | 50.05 |
| Profit Before Tax | 351.43 | 495.88 | 409.20 | 320.06 | 241.16 |
| Current Tax | 86.29 | 118.96 | 99.83 | 79.53 | 58.49 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.87 | 3.95 | 4.63 | 2.40 | 4.10 |
| Reported Net Profit | 263.27 | 372.96 | 304.73 | 238.13 | 178.57 |
| Extraordinary Items | 22.35 | 27.50 | 10.48 | 2.70 | 3.86 |
| Adjusted Net Profit | 240.92 | 345.46 | 294.25 | 235.43 | 174.71 |
| Adjustment below Net Profit | 55.78 | 5.97 | -0.01 | 0.26 | -0.56 |
| Profit/Loss Balance carried down | 1,691.00 | 1,403.60 | 1,170.33 | 985.51 | 878.02 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 111.94 | 91.54 | 71.45 | 53.56 | 70.52 |
| P & L Balance carried down | 1,898.10 | 1,691.00 | 1,403.60 | 1,170.33 | 985.51 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 755.00 | 875.00 | 875.00 | 683.00 | 51.20 |
| Dividend Per Share(Rs) | 7.55 | 10.70 | 8.75 | 6.83 | 5.12 |
| Earnings Per Share-Unit Curr | 25.17 | 35.65 | 29.13 | 22.76 | 187.76 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 193.06 | 173.27 | 145.80 | 123.50 | 1,164.13 |
| Book Value(Adj)-Unit Curr | 193.06 | 173.27 | 145.80 | - | - |
